CIK 0001533998 · Non-accelerated filer<br>Smaller reporting company
DarioHealth Corp.
Sign in to watch- Ticker
- DRIO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452973162
- Phone
- 972-4-770-6377
- Business address
- 322 W 57TH ST. #33B, NEW YORK, NY, 10019
- Former names
- LabStyle Innovations Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-19 | Raphael Erez Chief Executive Officer | Purchase | +5,000 | $0.90 | $5K | 1,922,059 |
| 2024-08-16 | Raphael Erez Chief Executive Officer | Purchase | +2,000 | $0.89 | $2K | 1,914,059 |
| 2024-08-16 | Raphael Erez Chief Executive Officer | Purchase | +3,000 | $0.90 | $3K | 1,917,059 |
| 2024-08-12 | Shaked Yoav Director | Conversion | +772 | $19.10 | $15K | 33,582 |
| 2024-08-12 | Shaked Yoav Director | Conversion · Series B-2 Preferred Stock | −40 | $1,000.00 | $40K | 0 |
| 2024-08-12 | Raphael Erez Chief Executive Officer | Conversion | +579 | $19.10 | $11K | 157,432 |
| 2024-08-12 | Raphael Erez Chief Executive Officer | Conversion · Series B-2 Preferred Stock | −30 | $1,000.00 | $30K | 0 |
| 2024-08-12 | Matheis Dennis Director | Conversion | +965 | $19.10 | $18K | 28,596 |
| 2024-08-12 | Matheis Dennis Director | Conversion · Series B-2 Preferred Stock | −50 | $1,000.00 | $50K | 0 |
| 2024-06-05 | Nelson Steven Charles Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +500,000 | 500,000 | ||
| 2024-06-05 | Nelson Steven Charles Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2024-06-05 | Nelson Steven Charles Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +1,200,000 | 1,350,000 | ||
| 2024-03-06 | Ben-David Zvi Chief Financial Officer | Grant or award | +400,000 | 746,035 | ||
| 2024-03-06 | Shaked Yoav Director | Grant or award | +90,000 | 256,193 | ||
| 2024-03-06 | ANDERSON RICHARD ALAN President | Grant or award · Stock Option (right to buy) | +750,000 | 750,000 | ||
| 2024-03-06 | ANDERSON RICHARD ALAN President | Grant or award · Stock Option (right to buy) | +320,000 | 320,000 | ||
| 2024-03-06 | KAPLAN JON H. Director | Grant or award | +70,000 | 70,000 | ||
| 2024-03-06 | Karah Hila Director | Grant or award | +70,000 | 219,290 | ||
| 2024-03-06 | Raphael Erez Chief Executive Officer | Grant or award | +800,000 | 1,912,059 | ||
| 2024-03-06 | MCGRATH DENNIS M Director | Grant or award | +80,000 | 154,744 |
Page 3 of 13 · 253 trades